dulaglutide
Selected indexed studies
- Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial. (Lancet, 2019) [PMID:31189511]
- Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial. (Lancet Diabetes Endocrinol, 2018) [PMID:29397376]
- Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASS-CVOT design and baseline characteristics. (Am Heart J, 2024) [PMID:37758044]
_Worker-drafted node — pending editorial review._
Connections
dulaglutide is a side effect of
Sources
- Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial. (2019) pubmed
- Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial. (2018) pubmed
- Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASS-CVOT design and baseline characteristics. (2024) pubmed
- Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes. (2025) pubmed
- Efficacy and safety of tirzepatide monotherapy compared with dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono): a double-blind, multicentre, randomised, phase 3 trial. (2022) pubmed
- Comparison of Dose Escalation Versus Switching to Tirzepatide Among People With Type 2 Diabetes Inadequately Controlled on Lower Doses of Dulaglutide : A Randomized Clinical Trial. (2025) pubmed
- Once-Weekly Dulaglutide for the Treatment of Youths with Type 2 Diabetes. (2022) pubmed
- Effects of dulaglutide on alcohol consumption during smoking cessation. (2023) pubmed
- Mazdutide versus dulaglutide in Chinese adults with type 2 diabetes. (2026) pubmed
- Dulaglutide: A Review in Type 2 Diabetes. (2020) pubmed